等待開盤 09-20 09:30:00 美东时间
+0.020
+1.23%
Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and raises the price target from $43 to $44.
09-13 01:58
HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP),
08-27 06:48
NRx Pharmaceuticals (NASDAQ:NRXP) subsidiary, HOPE Therapeutics, Monday reported the signing of a non-binding term sheet for non-dilutive, nonconvertible debt acquisition funding of its first interven...
08-26 20:06
NRX Pharmaceuticals (NRXP) just unveiled an announcement. NRx Pharmaceuticals, ...
08-21 04:59
NRx Pharmaceuticals (NASDAQ:NRXP) on Tuesday said it has obtained up to about $16 million in convertible debt financing from an institutional investor. The company intends to use the net proceeds from...
08-13 21:03
Petition for a temporary restraining order brought by Streeterville Capital, LLC seeking injunctive relief to prevent spinoff of 49% of HOPE Therapeutics shares to current NRx Shareholders h...
07-29 20:30
NRX Pharmaceuticals (NRXP) has provided an announcement. NRx Pharmaceuticals, I...
06-28 05:17
The June 2024 meeting of the American Society for Clinical Psychopharmacology (ASCP) focused heavily on increasing use of intravenous ketamine and intranasal S-ketamine as the emerging stand...
06-10 20:30
Major earnings expected after the bell on Tuesday include: Oxford Lane Capital Corp. (OXLC) Capital Southwest Corporation (CSWC) Seadrill Limited (SDRL) Nu Holdings Ltd. (NU) Canoo (GOEV) Other earnin...
05-14 05:35
Gainers: XBP Europe Holdings (XBP) +68%. Perficient (PRFT) +53% Q1 earnings call release Strong Global Entertainment (SGE) +52% to acquire Strong/MDI Screen Systems Beneficient (BENF) +19%. Allarit...
05-06 20:39